Bliss GVS Pharma Ltd Q1 FY2026 consolidated net profit surges to Rs. 43.03 crores

Bliss GVS Pharma Limited has reported Consolidated financial results for the period ended June 30, 2025.

Financial Results (Q1 FY2026) - QoQ Comparison

The company has reported total income of Rs. 242.9232 crores during the period ended June 30, 2025 as compared to Rs. 210.0543 crores during the period ended March 31, 2025.

The company has posted net profit / (loss) of Rs. 43.0379 crores for the period ended June 30, 2025 as against net profit / (loss) of Rs. 15.5391 crores for the period ended March 31, 2025.

The company has reported EPS of Rs. 4.04 for the period ended June 30, 2025 as compared to Rs. 1.46 for the period ended March 31, 2025.

Financials	Q1 FY2026	Q4 FY2025	% Change
Total Income	₹ 242.9232 crs	₹210.0543 crs	15.65%
Net Profit	₹43.0379 crs	₹15.5391 crs	176.97%
EPS	₹4.04	₹1.46	176.71%

Financial Results (Q1 FY2026) - YoY Comparison

The company has reported total income of Rs. 242.9232 crores during the period ended June 30, 2025 as compared to Rs.187.7654 crores during the period ended June 30, 2024.

The company has posted net profit / (loss) of Rs.43.0379 crores for the period ended June 30, 2025 as against net profit / (loss) of Rs.20.6974 crores for the period ended June 30, 2024.

The company has reported EPS of Rs.4.04 for the period ended June 30, 2025 as compared to Rs.1.93 for the period ended June 30, 2024.

Financials	Q1 FY2026	Q1 FY2025	% Change
Total Income	₹ 242.9232 crs	₹187.7654 crs	29.38%
Net Profit	₹43.0379 crs	₹20.6974 crs	107.94%
EPS	₹4.04	₹1.93	109.33%

Shares of Bliss GVS Pharma Limited was last trading in BSE at Rs. 155.65 as compared to the previous close of Rs. 155.10. The total number of shares traded during the day was 16397 in over 723 trades.

The stock hit an intraday high of Rs. 159.15 and intraday low of 154.00. The net turnover during the day was Rs. 2562036.00.

Source : Equity Bulls

Keywords

BlissGVSPharma Q1FY26 Q1FY2026 FY2026 ResultUpdate